|
業務類別
|
Medical Instruments & Supplies |
|
業務概覽
|
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world. |
| 公司地址
| Chemin de Blandonnet 8, Vernier, Geneva, CHE, 1214 |
| 電話號碼
| +41 589112000 |
| 傳真號碼
| +41 589113222 |
| 公司網頁
| https://www.alcon.com |
| 員工數量
| 25942 |
| Mr. David J. Endicott |
Director and Chief Executive Officer |
美元 1.43M |
24/02/2026 |
| Mr. Timothy C. Stonesifer |
Senior Vice President and Chief Financial Officer |
-- |
24/02/2026 |
| Mr. Leon Sergio Duplan Fraustro |
Senior Vice President and President, Americas |
-- |
24/02/2026 |
| Mr. Ian Bell |
Senior Vice President and Chief Operating Officer |
-- |
24/02/2026 |
| Mr. Laurent Attias |
Senior Vice President, Corporate Strategy, Business Development and Licensing and Mergers and Acquisitions |
-- |
24/02/2026 |
| Mr. Rajkumar Narayanan |
Senior Vice President and President, International |
-- |
24/02/2026 |
| Ms. Kimberly Martin |
Senior Vice President and Chief Human Resources and Corporate Communication Officer |
-- |
24/02/2026 |
|
|
| Mr. Thomas H. Glanzmann |
Independent Director |
24/02/2026 |
| Mr. D. Keith Grossman |
Vice Chairman of the Board |
24/02/2026 |
| Mr. F. Michael Ball |
Chairman of the Board |
24/02/2026 |
| Ms. Karen J. May |
Independent Director |
24/02/2026 |
| Mr. Scott H. Maw |
Independent Director |
24/02/2026 |
| Mr. Dieter Spalti, PhD |
Independent Director |
24/02/2026 |
| Mr. David J. Endicott |
Director and Chief Executive Officer |
24/02/2026 |
| Ms. Lynn Dorsey Bleil |
Independent Director |
24/02/2026 |
| Dr. Arthur Cummings, M.D. |
Independent Director |
24/02/2026 |
| Ms. Ines Poschel |
Independent Director |
24/02/2026 |
| Ms. Deborah DiSanzo |
Independent Director |
24/02/2026 |
|
|
|
|
